collection
https://read.qxmd.com/read/27496262/amiodarone-or-lidocaine-for-cardiac-arrest-a-systematic-review-and-meta-analysis
#21
REVIEW
F Sanfilippo, C Corredor, C Santonocito, G Panarello, A Arcadipane, G Ristagno, T Pellis
BACKGROUND: Guidelines for treatment of out-of-hospital cardiac arrest (OOH-CA) with shockable rhythm recommend amiodarone, while lidocaine may be used if amiodarone is not available. Recent underpowered evidence suggests that amiodarone, lidocaine or placebo are equivalent with respect to survival at hospital discharge, but amiodarone and lidocaine showed higher hospital admission rates. We undertook a systematic review and meta-analysis to assess efficacy of amiodarone vs lidocaine vs placebo...
October 2016: Resuscitation
https://read.qxmd.com/read/27434349/amiodarone-and-cardiac-arrest-systematic-review-and-meta-analysis
#22
REVIEW
Ageliki Laina, George Karlis, Aris Liakos, Georgios Georgiopoulos, Dimitrios Oikonomou, Evangelia Kouskouni, Athanasios Chalkias, Theodoros Xanthos
INTRODUCTION: The 2015 Guidelines for Resuscitation recommend amiodarone as the antiarrhythmic drug of choice in the treatment of resistant ventricular fibrillation or pulseless ventricular tachycardia. We reviewed the effects of amiodarone on survival and neurological outcome after cardiac arrest. METHODS: We systematically searched MEDLINE and Cochrane Library from 1940 to March 2016 without language restrictions. Randomized control trials (RCTs) and observational studies were selected...
October 15, 2016: International Journal of Cardiology
https://read.qxmd.com/read/31941354/survival-after-intravenous-versus-intraosseous-amiodarone-lidocaine-or-placebo-in-out-of-hospital-shock-refractory-cardiac-arrest
#23
RANDOMIZED CONTROLLED TRIAL
Mohamud R Daya, Brian G Leroux, Paul Dorian, Thomas D Rea, Craig D Newgard, Laurie J Morrison, Joshua R Lupton, James J Menegazzi, Joseph P Ornato, George Sopko, Jim Christenson, Ahamed Idris, Purav Mody, Gary M Vilke, Caroline Herdeman, David Barbic, Peter J Kudenchuk
BACKGROUND: Antiarrhythmic drugs have not proven to significantly improve overall survival after out-of-hospital cardiac arrest from shock-refractory ventricular fibrillation/pulseless ventricular tachycardia. How this might be influenced by the route of drug administration is not known. METHODS: In this prespecified analysis of a randomized, placebo-controlled clinical trial, we compared the differences in survival to hospital discharge in adults with shock-refractory ventricular fibrillation/pulseless ventricular tachycardia out-of-hospital cardiac arrest who were randomly assigned by emergency medical services personnel to an antiarrhythmic drug versus placebo in the ALPS trial (Resuscitation Outcomes Consortium Amiodarone, Lidocaine or Placebo Study), when stratified by the intravenous versus intraosseous route of administration...
January 21, 2020: Circulation
https://read.qxmd.com/read/25887120/the-administration-of-dextrose-during-in-hospital-cardiac-arrest-is-associated-with-increased-mortality-and-neurologic-morbidity
#24
JOURNAL ARTICLE
Teng J Peng, Lars W Andersen, Brian Z Saindon, Tyler A Giberson, Won Young Kim, Katherine Berg, Victor Novack, Michael W Donnino
INTRODUCTION: Dextrose may be used during cardiac arrest resuscitation to prevent or reverse hypoglycemia. However, the incidence of dextrose administration during cardiac arrest and the association of dextrose administration with survival and other outcomes are unknown. METHODS: We used the Get With The Guidelines®-Resuscitation national registry to identify adult patients with an in-hospital cardiac arrest between the years 2000 and 2010. To assess the adjusted effects of dextrose administration on survival, we used multivariable regression models with adjustment for multiple patient, event, and hospital characteristics...
April 10, 2015: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/34587236/effect-of-vasopressin-and-methylprednisolone-vs-placebo-on-return-of-spontaneous-circulation-in-patients-with-in-hospital-cardiac-arrest-a-randomized-clinical-trial
#25
RANDOMIZED CONTROLLED TRIAL
Lars W Andersen, Dan Isbye, Jesper Kjærgaard, Camilla M Kristensen, Søren Darling, Stine T Zwisler, Stine Fisker, Jens Christian Schmidt, Hans Kirkegaard, Anders M Grejs, Jørgen R G Rossau, Jacob M Larsen, Bodil S Rasmussen, Signe Riddersholm, Kasper Iversen, Martin Schultz, Jakob L Nielsen, Bo Løfgren, Kasper G Lauridsen, Christoffer Sølling, Kim Pælestik, Anders G Kjærgaard, Dorte Due-Rasmussen, Fredrik Folke, Mette G Charlot, Rikke Malene H G Jepsen, Sebastian Wiberg, Michael Donnino, Tobias Kurth, Maria Høybye, Birthe Sindberg, Mathias J Holmberg, Asger Granfeldt
IMPORTANCE: Previous trials have suggested that vasopressin and methylprednisolone administered during in-hospital cardiac arrest might improve outcomes. OBJECTIVE: To determine whether the combination of vasopressin and methylprednisolone administered during in-hospital cardiac arrest improves return of spontaneous circulation. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, double-blind, placebo-controlled trial conducted at 10 hospitals in Denmark...
October 26, 2021: JAMA
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.